Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NOVO NORDISK - NUF
NUF
Active
Org 936227007
Novo Alle 1,
Dk-2880 Bagsværd
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2025
— employees
Watchlist
Share
Norway
/
Companies
/
Manufacture of pharmaceutical preparations
/
NOVO NORDISK - NUF
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MB
Marianne Berg
Chief Executive Officer
Chief Executive Officer
2025
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on NOVO NORDISK - NUF
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
